Skip to main content

Aralia Racemosa MT

Generic: Aralia Racemosa

Verified·Apr 23, 2026
NDC
66096-751
Route
ORAL
ICD-10 indication
J45.909

Affordability Check

How much will you actually pay for Aralia Racemosa MT?

In 30 seconds, see every legitimate way to afford Aralia Racemosa MT — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Aralia Racemosa MT

What is this medication?

Aralia Racemosa MT is a homeopathic mother tincture prepared from the plant commonly known as American Spikenard. This medication is primarily used in alternative medicine to address various respiratory conditions and allergic reactions, such as hay fever and allergic rhinitis. It is particularly effective for individuals experiencing symptoms like persistent sneezing, a watery nasal discharge, and a feeling of obstruction in the nasal passages.

In addition to treating upper respiratory issues, this tincture is often utilized to relieve chest tightness and a dry, hacking cough that tends to worsen when the patient lies down. It is frequently indicated for conditions like asthma where the symptoms are triggered by exposure to cold air or allergens. By helping to clear mucus and soothe throat irritation, this remedy supports easier breathing and provides relief from the characteristic tickling sensation that often precedes a coughing fit.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Aralia Racemosa MT. Official source: DailyMed (NLM) · Label effective Dec 28, 2021

Indications and usage
Batch no. 40021 Restest Date: 11/2022
Warnings
Caution: for manufacturing,processing or repacking only. Caution: for manufacturing, processing or repacking only.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.